8-KEarnings & ResultsRegulation FDOther Events+1

BeOne Medicines Ltd. 8-K Report, Financial Results (Aug 8, 2019)

Filed August 8, 2019For Securities:ONCBEIGF

Summary

BeiGene, Ltd. (ONC) filed an 8-K on August 8, 2019, to report its second quarter 2019 financial results and provide business updates. The company announced its financial performance for the three and six months ended June 30, 2019, through a press release, which is included as an exhibit to the filing. Investors should note that this report also incorporates an investor presentation and provides an update on recent business highlights and future milestones expected through 2020. The filing indicates that key business developments and strategic outlook were communicated on this date. While the specific financial figures for the quarter are not detailed in the provided text, the 8-K serves as a formal announcement and consolidation point for these important disclosures, including forward-looking statements that offer insights into the company's trajectory.

Key Highlights

  • 1Announcement of Q2 2019 financial results (three and six months ended June 30, 2019).
  • 2Inclusion of a press release detailing financial performance as Exhibit 99.1.
  • 3Disclosure of an investor presentation dated August 8, 2019, as Exhibit 99.2, available on the company's website.
  • 4Update on recent business highlights and anticipated milestones for the remainder of 2019 and 2020 provided in the press release.
  • 5Forward-looking statements are included, offering insights into future expectations and plans.
  • 6The filing integrates information from the press release and investor presentation by reference into specific items of the 8-K.
  • 7Information furnished under Regulation FD (Item 7.01) is not deemed 'filed' under Section 18 of the Exchange Act unless expressly incorporated by reference in a filing.

Frequently Asked Questions

The detailed financial results for the three and six months ended June 30, 2019, are available in the press release issued by BeiGene, Ltd. on August 8, 2019, which is attached as Exhibit 99.1 to this Form 8-K filing.

In addition to financial results, this 8-K includes an investor presentation (Exhibit 99.2) and an update on recent business highlights and expected milestones for the rest of 2019 and 2020. This information is intended to provide investors with a comprehensive view of the company's performance and strategic direction.

The press release (Exhibit 99.1) and the investor presentation (Exhibit 99.2) are incorporated by reference into the 8-K. However, the information furnished under Item 7.01 (Regulation FD Disclosure), including the investor presentation, is generally considered 'furnished' and not 'filed' for purposes of Section 18 of the Exchange Act, unless specifically stated otherwise.

The business updates and milestones provided in the press release cover recent second quarter 2019 activities and extend to expected developments for the remainder of 2019 and into 2020.